Literature DB >> 33941445

Long-term evaluation of temporomandibular disorders in association with cytokine and autoantibody status in young women.

Chunghwan Son1, Yoon Kyung Park2, Ji Woon Park3.   

Abstract

Temporomandibular disorders (TMD) is a chronic pain disease affecting 4-60% of general population. Its suggested etiology includes mechanical overloading to related structures, psychosocial factors, and genetic vulnerability. However, its pathogenesis is yet to be fully understood, especially in cases with a higher level of pain and more associated comorbidities. Recently chronic systemic inflammation and possible autoimmunity has been indicated in several pain conditions as the underlying mechanism of chronicity but this aspect has not been rigorously investigated in TMD. This article focuses on analyzing the levels of cytokines, chemokines, autoantibodies and nonspecific inflammatory markers and comparing their levels according to pain severity and duration in 66 female TMD patients in their 20 s and investigating their association with clinical indices of TMD and comorbidities. The high pain disability group showed decreased range of jaw function and more pain on palpation of capsule areas compared to the low pain disability group. Comorbidities such as anxiety and sleep disturbance were also significantly more prevalent. The level of IL-8 and IgG were significantly higher in the high pain disability group. IL-2, -8, -13, IFN- γ, RANTES, PGE2, and thrombopoietin levels showed a significant effect on indices reflecting jaw function, generalized pain intensity, and health related quality of life. Such results imply that longer pain duration and higher pain intensity is associated with higher levels of systemic inflammation suggesting the possible role of immunologic disturbance as an underlying factor of chronic TMD pain and warranting further investigation for its consideration in diagnosis and treatment.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoantibody; Comorbidity; IL-8; IgG; Temporomandibular Disorders

Mesh:

Substances:

Year:  2021        PMID: 33941445     DOI: 10.1016/j.cyto.2021.155551

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  4 in total

1.  Circulating Omega-6 and Omega-3 Polyunsaturated Fatty Acids in Painful Temporomandibular Disorder and Low Back Pain.

Authors:  Anne E Sanders; E Diane Weatherspoon; Brandie M Ehrmann; Paul S Soma; Saame R Shaikh; John S Preisser; Richard Ohrbach; Roger B Fillingim; Gary D Slade
Journal:  J Pain       Date:  2022-06-10       Impact factor: 5.383

Review 2.  Oxygen-Ozone Therapy for Reducing Pro-Inflammatory Cytokines Serum Levels in Musculoskeletal and Temporomandibular Disorders: A Comprehensive Review.

Authors:  Alessandro de Sire; Nicola Marotta; Martina Ferrillo; Francesco Agostini; Cristiano Sconza; Lorenzo Lippi; Stefano Respizzi; Amerigo Giudice; Marco Invernizzi; Antonio Ammendolia
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

Review 3.  Action of Hyaluronic Acid as a Damage-Associated Molecular Pattern Molecule and Its Function on the Treatment of Temporomandibular Disorders.

Authors:  Natália Dos Reis Ferreira; Carolina Kaminski Sanz; Aline Raybolt; Cláudia Maria Pereira; Marcos Fabio DosSantos
Journal:  Front Pain Res (Lausanne)       Date:  2022-03-18

4.  Does physical activity level have an impact on long-term treatment response in temporomandibular disorders: protocol for a prospective study.

Authors:  Youngwoo Chun; Jung Hwan Jo; Ji Woon Park
Journal:  BMC Oral Health       Date:  2022-09-14       Impact factor: 3.747

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.